Kelishadi Roya, Qorbani Mostafa, Heshmat Ramin, Motamed-Gorji Nazgol, Motlagh Mohammad Esmaeil, Ziaodini Hasan, Taheri Majzoubeh, Shafiee Gita, Aminaee Tahereh, Ahadi Zeinab, Heidari-Beni Motahar
MD. Professor, Department of Pediatrics, Child Growth and Development Research Center, Research Institute for Primordial Prevention of Noncommunicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.
PhD. Epidemiologist andAssistant Professor,Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran; and Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Sao Paulo Med J. 2018 Nov-Dec;136(6):511-519. doi: 10.1590/1516-3180.2018.0161161118.
It has been suggested that the levels of some liver enzymes, and especially alanine aminotransferase (ALT), might be correlatable with cardiometabolic risk factors. We investigated the relationship between ALT concentration and cardiometabolic risk factors among children and adolescents.
This nationwide study in Iran was conducted within the framework of the fifth survey of a national surveillance program known as the Childhood and Adolescence Surveillance and PreventIon of Adult Non-communicable disease study (CASPIAN-V).
The participants comprised 4200 students aged 7-18 years, who were recruited through multi-stage random cluster sampling in 30 provinces in Iran. Physical examinations and laboratory tests were conducted in accordance with standard protocols.
Overall, 3843 students (participation rate: 91.5%) completed the survey. Mean ALT levels were significantly higher in individuals with dyslipidemia, in terms of elevated total cholesterol (TC) or LDL-cholesterol or triglycerides (TG), excess weight and dyslipidemia. Some cardiometabolic risk factors were associated with higher levels of ALT, with the following odds ratio (OR) and 95% confidence interval (CI):metabolic syndrome (OR: 1.013; 95% CI: 1.001-1.025); elevated TC (OR: 1.060; 95% CI: 1.039-1.081), elevated LDL (OR: 1.031; 95% CI: 1.016-1.046), elevated TG (OR: 1.056; 95% CI: 1.040-1.072) and dyslipidemia (OR: 1.051; 95% CI: 1.034-1.068).
This large population-based study revealed that some cardiometabolic risk factors were significantly associated with ALT levels. These findings suggest that an association with fatty liver is an underlying mechanism for development of cardiometabolic risk factors.
有人提出,某些肝酶水平,尤其是丙氨酸氨基转移酶(ALT),可能与心脏代谢风险因素相关。我们调查了儿童和青少年中ALT浓度与心脏代谢风险因素之间的关系。
这项在伊朗开展的全国性研究是在一项名为儿童和青少年成人非传染性疾病监测与预防研究(CASPIAN-V)的国家监测计划的第五次调查框架内进行的。
参与者包括4200名7至18岁的学生,他们通过多阶段随机整群抽样在伊朗的30个省份招募。根据标准方案进行体格检查和实验室检查。
总体而言,3843名学生(参与率:91.5%)完成了调查。在血脂异常(以总胆固醇(TC)、低密度脂蛋白胆固醇或甘油三酯(TG)升高为指标)、超重和血脂异常的个体中,平均ALT水平显著更高。一些心脏代谢风险因素与较高的ALT水平相关,其比值比(OR)和95%置信区间(CI)如下:代谢综合征(OR:1.013;95%CI:1.001-1.025);TC升高(OR:1.060;95%CI:1.039-1.081),低密度脂蛋白升高(OR:1.03(此处原文有误,应为1.031);95%CI:1.016-1.046),TG升高(OR:1.056;95%CI:1.040-1.072)和血脂异常(OR:1.051;95%CI:1.034-1.068)。
这项基于大量人群的研究表明,一些心脏代谢风险因素与ALT水平显著相关。这些发现表明,与脂肪肝的关联是心脏代谢风险因素发展的潜在机制。